ongoing collaboration projects
| name | PI and coord. centre |
SHCS representiatives |
topic | region |
| ACHIeV2E A collaboration on HIV-2 infection |
Linda Wittkop, France | J. Böni (lab), A. Calmy (clinic) |
Diagnosis, natural history, and ART of HIV-2 Infection | 13 cohorts from Europe, Africa, North America |
| ATHENA, AQUITAINE, ICONA, ARCA 5 European cohort collaboration SHCS #816 |
Flaminia Olearo, HUG | A. Calmy, R. Kouyos |
The impact of mutations on the effectiveness of abacavir/lamivudine/dolutegravir regimens prescribed in treatment-experienced patients | Europe |
| BEEHIVE Bridging the evolution and epidemiology of HIV in Europe |
Christoph Fraser, Oxford University, Oxford | H. Günthard, R. Kouyos |
Evolution and Epidemiology of HIV in Europe | European Community (UK, Netherlands, Switzerland) |
| Causal effect of treatment on survival from HIV/AIDS | O. Aalen, Norway, J. Sterne, Bristol Univ, UK |
B. Ledergerber | ||
| Cellular Immune Responses and Immuneactivation against HIV | A. Oxenius, ETHZ | H. Günthard | Study cellular immune responses and activation of CD4 and CD8 cells | |
| Effect of TDF on HCC incidence | A. Rauch, G. Wandeler |
A. Rauch | Assessing the effect of HBV therapy on HCC in HIV-infected patients | Europe |
| EPPICC European Pregnancy and Paediatric HIV Cohort Collaboration |
T. Klimkait | |||
| HBV outcomes in HIV/HBV-coinfected nd HBV-monoinfected patients in Switzerland | G. Wandeler | A. Rauch | Comparison of HBV virological outcomes between HIV and HIV-uninfected individuals | |
| HIV CAUSAL HIV Causal Collaboration #498 |
M. Hernan, Harvard School of Public Health, Boston, USA | H. Bucher, M. Egger |
When to start HAART? Best initial regimen? When to switch HAART? | 12 cohorts from USA and Europe |
| ICGH International Collaboration for the Genomics of HIV |
a consortium of 25 cohorts / studies coordinated by the SHCS | J. Fellay | A collaborative research effort of all groups active in host genomics of HIV disease | America, Europe, Africa, Australia |
| IeDEA-hepatitis Long-term hepatitis B outcomes in HIV-infected patients in southern Africa and Switzerland |
G. Wandeler, ISPM Bern | G. Wandeler, A. Rauch |
HIV/HBV-coinfection cohorts | sub-Saharan Africa |
| Kinetics of Hepatitis B Virus markers in treated HIV/HBV-coinfected patients | G. Wandeler, ISPM Bern |
G. Wandeler, A. Rauch |
Assessing the dynamics of HBV markers in HIV/HBV coinfected patients | Europe |
| LoHRA Low HBV Replication and Adherence in Long-term TDF/&ETV-treated HIV-HBV infected patients |
K. Lacombe, Paris | A. Rauch, G. Wandeler |
Evaluating impact of low-level HBV replication in HIV-infected patients | Europe |
| Mathematical modelling and spread of HIV drug resistance at the population level in the SHCS | S. Bonhoeffer, ETHZ, T. Stadler, ETHZ |
H. Günthard | Poplulation mathematical modelling of spread of HIV drug resistance on the population level | |
| Modelling hepatitis C treatment-as-preventions strategies | A. Rauch | A. Rauch, L. Salazar |
Evaluation treatment-as-prevention to curb the HCV epidemics | Australia |
| Multi-cohort study to inform hepatocellular carcinoma screening strategies in HIV/HBV-coinfected individuals on tenofovir-containing therapy | G. Wandeler, ISPM Bern |
G. Wandeler, A. Rauch |
Investigating and improving progonstic score for HCC screening in HIV-infected patients | Europe |
| Multiple projects in Tanzania | Swiss Tropical and Public Health Institute, Basel | M. Battegay, H. Furrer |
Tanzania | |
| NESCent The evolution of virulence in a human infectious disease: the case study of HIV |
J. Herbeck, V. Müller |
H. Günthard | HIV virulence over time in large global cohort collaborations | several Western European, American and most likely also African cohorts |
| Penta-EICG European infant collaboration |
C. Gianquinto, Fondazion Penta-Onlus, Padova, Italy | C. Rudin, P. Paioni |
Treatment of children | several European |
| PopGen Population kinetic modelling of metabolic traits in HIV-infected individuals |
C. Czajka, University of Lausanne | P. Tarr | Development of a population kinetics model to describe the dynamics and interindividual variability of metabolic traits after ART initiation | |
| Principals of collaboration with the National Institute for Cancer Epidemiology and Registration (NICER) | R. Heusser, NICER | M. Egger | Linkage study with Swiss CR | |
| RESPOND International Cohort Consortium on Infectious Diseases |
Amanda Mocroft, Jens Lundgren |
H. Günthard, A. Scherrer |
Long term outcomes in HIIV-infected individuals: aging, comorbididies, ART etc. | Europe |
| TB:HIV Co-infection with mycobacterium tuberculosis among HIV patients P501 and P663 |
Jens Lundgren, CHIP, DK | H. Furrer | Co-infection with TB | several Eastern & Western European |